In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...
A new shot is helping protect more babies from RSV. A Dayton doctor said it is already dramatically reducing hospitalizations ...
HOUSTON, Texas (KTRK) -- Typically, doctors see more cases of respiratory syncytial virus, known as RSV, in the winter months in Texas. However, cases were relatively low this past winter and doctors ...
Scientists have uncovered strong evidence that infection with RSV in the first months of life can significantly raise the ...
NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...
Here are five things parents and caregivers should know about the new vaccination schedule changes for children. The new ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA advisors ...
Nirsevimab, a long-acting monoclonal antibody that confers passive immunity for infants up to 6 months old, was approved in 2023 to prevent RSV-related LRTIs in infants in their first year of life, as ...
An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually experience RSV as a mild cold, infants can develop more severe conditions, ...
Local reporting and CDC maps indicate that flu and RSV infections are rising in Georgia, with doctors observing an uptick in ...
Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...
PHILADELPHIA (WPVI) -- A host of viruses go around every winter, but RSV is one that causes a lot of concern for the parents of very young children. Coughing, sneezing and kids blowing noses, it's the ...